Donate
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program
BMJ
2024
Glob Heart
2023
Implementation Science Communications
Cochrane Database of Systematic Reviews